Supplementary Figure S5 from BCL2 Inhibition Reveals a Dendritic Cell–Specific Immune Checkpoint That Controls Tumor Immunosurveillance

<p>Supplementary Figure S5 contains evidence indicating that BCL2 inhibitors synergize with immune checkpoint blockades in different mouse orthotopic cancer models.</p>